Healthleap, a startup whose software combs through hospital patients' medical records overnight looking for signs of missed diagnoses, has raised $38 million in combined seed and Series A funding, the company told TechCrunch. The round comes a year after the company had just three hospital customers; it now has more than 50.
The funding splits into an $8 million seed round co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures. The company, founded in South Africa in 2022 by siblings Josiah and Jemima Meyer, did not disclose its new valuation.
From a Nutrition Tool to a General Risk Platform
Healthleap's platform connects to a hospital's electronic health record system and uses language models to pull clinical signals — things like documented weight loss or trouble swallowing — out of doctors' and nurses' free-text notes, then combines them with labs and vitals in a risk model. Each night it scores every adult inpatient; each morning, care teams see flagged patients in their existing workflow. The company says the tool does not diagnose conditions, only surfaces patients who may warrant a closer look.
The platform began as a tool to catch malnutrition, which research cited by the company estimates costs the U.S. healthcare system up to $58 billion a year largely because it goes undiagnosed in hospitalized patients. Malnutrition and delirium screening are now live with customers; screening for aspiration pneumonia, pressure ulcers and congestive-heart-failure readmission risk are in clinical validation. Healthleap's customer list includes Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist and Emory Healthcare. At the University of Pennsylvania's hospital, the company says its malnutrition program alone delivers $23.8 million a year in financial impact — split between added insurance reimbursement and shorter hospital stays — though that figure comes from the company and has not been independently verified.
Healthleap sells three-year contracts priced by a hospital's licensed bed count, with an outcomes-based component; the company says every customer has hit at least a 5x return on the contract's cost, validated by hospital finance teams. CEO Josiah Meyer said the new capital will go toward engineering, sales and customer-success hires as the company expands beyond its current conditions toward a longer list of more than 40 the founders eventually want to screen for, plus outpatient and home-care settings. The company's growth — more than tenfold revenue growth over the past year, on its own account — arrives amid a broader surge in hospital systems adopting AI tools to manage staffing shortages and reimbursement pressure, a trend that has drawn venture money into a crowded field of clinical AI startups competing for the same hospital IT budgets.